Our Weight Loss Trials
A 51-week, placebo-controlled study evaluating the effectiveness of different dosages of a new investigational weight loss injectable treatment.
This study is being conducted as our Central Coast Western Sydney and Canberra sites.
Apply NowA Phase 3 Clinical Trial Comparing the Effectiveness of a New Investigational Treatment with Tirzepatide in Managing Type 2 Diabetes Glycaemic Control and Weight Reduction.
This study is being conducted at our Western Sydney and Canberra sites.
Apply NowParatus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326